Consider bodyweight gain when prescribing atypical antipsychotics

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2001年 / 835卷 / 1期

关键词：

Clozapine; Risperidone; Olanzapine; Quetiapine; Atypical Antipsychotic;

D O I：

10.2165/00128415-200108350-00005

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Bodyweight gain with atypical antipsychotics - A comparative review
Wetterling, T
DRUG SAFETY, 2001, 24 (01) : 59 - 73
[2] Atypical antipsychotics and bodyweight gain: how serious is the problem?
Drugs & Therapy Perspectives, 2002, 18 (8) : 23 - 26
[3] Bodyweight gain associated with atypical antipsychotics - Epidemiology and therapeutic implications
Russell, JM
Mackell, JA
CNS DRUGS, 2001, 15 (07) : 537 - 551
[4] Caution is still needed when prescribing atypical antipsychotics
Carey, Stephen
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (05) : 299 - 299
[5] Comparison of bodyweight gain with new antipsychotics
Reactions Weekly, 1999, 761 (1) : 4 - 4
[6] Prescribing of atypical antipsychotics
Toal, M
Campbell, H
BRITISH JOURNAL OF PSYCHIATRY, 1998, 173 : 85 - 85
[7] Prescribing of atypical antipsychotics
Appadoo, R
Ashton, C
Carlton, T
BRITISH JOURNAL OF PSYCHIATRY, 1998, 173 : 85 - 85
[8] Predictive factors for bodyweight gain with antipsychotics identified
Reactions Weekly, 2001, 864 (1) : 5 - 5
[9] Little known about bodyweight gain with antipsychotics
Reactions Weekly, 2001, 863 (1) : 2 - 2
[10] Selective prescribing of atypical antipsychotics
Breekveldt-Postma, NS
Schillevoort, I
Nolen, WA
Veraart, CPWM
Herings, RMC
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (01) : 25 - 30

← 1 2 3 4 5 →